AzTrials
AzTrials

Unilateral Complete Cleft LipNAMNCT01883726

Comparison of Two Nasoalveolar Molding Techniques in Complete Unilateral Cleft Lip Patient

A study testing Grayson's presurgical nasoalveolar molding and Figueroa's presurgical nasoalveolar molding in people with Unilateral Complete Cleft Lip, run by Chang Gung Memorial Hospital at 1 site in Taiwan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Two types of Presurgical Nasoalveolar Molding (NAM) coexist in Craniofacial Center in Chang Gung Memorial Hospital. The objective of this study is to compare the number of clinical visits, total prices, complications and nasal symmetry between these two NAM reconstruction methods. Read more about this study

Who is it for?
Ages 1 week to 3 months
Conditions the study is for
Unilateral Complete Cleft Lip
What is being tested?
Grayson's presurgical nasoalveolar molding and Figueroa's presurgical nasoalveolar molding
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteTaiwan
Study dates
May 2010to Jul 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 week to 3 months
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Complete unilateral cleft lip infant
  • Signed informed consent

Who cannot join

  • Incomplete unilateral cleft lip infant
  • Association of other craniofacial anomalies

Trial locations and contacts

1 site in 1 country.

Taiwan1 site
  • Chun-Shin, Chang

    Taipei, Taiwan, 333

Other trials in Taiwan

About this study

Two types of Presurgical Nasoalveolar Molding (NAM) coexist in Craniofacial Center in Chang Gung Memorial Hospital. The objective of this study is to compare the number of clinical visits, total prices, complications and nasal symmetry between these two NAM reconstruction methods.

Read the detailed description

Grayson's NAM reconstruction starts with alveolar molding first. The alveolar molding is made by gradual modification of the acrylic plate with periodic acrylic add on and grinding. After the alveolar cleft gap is less than 5 mm (usually at the end of second months), nasal molding was added to the alveolar molding plate.

Figueroa's NAM reconstruction use labial tapes and acrylic relief to the palatal plate to approximate alveolar gap. The device starts with nasal and alveolar molding simultaneously.

Being tested
Grayson's presurgical nasoalveolar molding, Figueroa's presurgical nasoalveolar molding
Keywords
Unilateral complete cleft lip, Nasoalveolar molding

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Grayson's presurgical nasoalveolar moldingDevice

    Grayson NAM

  • Figueroa's presurgical nasoalveolar moldingDevice

    Figueroa NAM

Study groups in NCT01883726
Study groupRoleWhat they receive
Grayson NAMExperimentalIntervention: Grayson nasoalveolar molding This technique uses an acrylic plate to mold the alveolar segments and uses an extension to mold the alar cartilage of the nasal component. The construction is made by gradual modification of the acrylic plate with periodic acrylic add on and grinding. When the alveolar gap is reduced to 5 mm, nasal component are added to gradually mold the nasal cartilage and other nasal structures.
Receives: Device: Grayson's presurgical nasoalveolar molding
Figueroa NAMExperimentalIntervention: Figueroa's nasoalveolar molding Figueroa technique uses labial tapes and acrylic relief to the palatal plate to approximate alveolar gap [3]. The nasal component is added in the beginning of the treatment to mold the nasal cartilage.
Receives: Device: Figueroa's presurgical nasoalveolar molding

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The nasal morphology - Nostril height 1

    Nostril height: the vertical distance between horizontal reference lines to the highest point of nostril aperture.

    Measured: (T1) at initial visit

  2. The nasal morphology - Nostril height 2

    Nostril height: the vertical distance between horizontal reference lines to the highest point of nostril aperture.

    Measured: (T2) after nasoalveolar molding (participants' nasoalveolar molding will be finished before surgery, an expected average of 3-months old)

  3. The nasal morphology - - Nostril height 3

    Nostril height: the vertical distance between horizontal reference lines to the highest point of nostril aperture.

    Measured: (T3) one week after surgery

  4. The nasal morphology - Nostril height 4

    Nostril height: the vertical distance between horizontal reference lines to the highest point of nostril aperture.

    Measured: (T4) 6 months after surgery

  5. The nasal morphology - Nostril width 1

    Nostril width: The widest horizontal distance between the inner medial and lateral border of nostril aperture.

    Measured: (T1) at initial visit

  6. The nasal morphology - Nostril width 2

    Nostril width: The widest horizontal distance between the inner medial and lateral border of nostril aperture.

    Measured: (T2) after nasoalveolar molding (participants' nasoalveolar molding will be finished before surgery, an expected average of 3-months old)

  7. The nasal morphology - Nostril width 3

    Nostril width: The widest horizontal distance between the inner medial and lateral border of nostril aperture.

    Measured: (T3) one week after surgery

  8. The nasal morphology - Nostril width 4

    Nostril width: The widest horizontal distance between the inner medial and lateral border of nostril aperture.

    Measured: (T4) 6 months after surgery

  9. The nasal morphology - Nasal sill height 3

    Nasal sill height: the vertical distance between the horizontal reference line to the lowest border of nostril aperture.

    Measured: (T3) one week after surgery

  10. The nasal morphology - Nasal sill height 4

    Nasal sill height: the vertical distance between the horizontal reference line to the lowest border of nostril aperture.

    Measured: (T4) 6 months after surgery

  11. The nasal morphology - nostril area 1

    Nostril area: the area presented by nostril aperture.

    Measured: (T1) at initial visit

  12. The nasal morphology - nostril area 2

    Nostril area: the area presented by nostril aperture.

    Measured: (T2) after nasoalveolar molding (participants' nasoalveolar molding will be finished before surgery, an expected average of 3-months old)

  13. The nasal morphology - nostril area 3

    Nostril area: the area presented by nostril aperture.

    Measured: (T3) one week after surgery

  14. The nasal morphology - nostril area 4

    Nostril area: the area presented by nostril aperture.

    Measured: (T4) 6 months after surgery

Secondary outcomes (4)
  1. duration of NAM

    Duration of NAM = Operation date - NAM initiation date

    Measured: From initial of nasoalveolar molding to finish of nasoalveolar molding (participants' nasoalveolar molding will be finished before surgery, an expected average of 3-months old)

  2. total number of visits before surgical correction

    Total number of orthodontic visit or NAM adjustment = number of adjustment of NAM

    Measured: From the initial visit to the date of surgery (participants' surgery will be performed on 3-month of age)

  3. cost of treatment

    Cost = cost of each visit of orthodontic and adjustment of NAM before surgery

    Measured: From initial orthodontic visit to finish of NAM (participants' nasoalveolar molding will be finished before surgery, an expected average of 3-months old)

  4. NAM complications

    Any complication like mucosa ulceration and facial skin irritation

    Measured: From initial of NAM to finish of NAM (participants' nasoalveolar molding will be finished before surgery, an expected average of 3-months old)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jun 2013 (estimated)
  2. Study startMay 2010
  3. Primary completionMay 2013
  4. Study completionJul 2013 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01883726
Sponsor's protocol ID
102-1267C
Acronym
NAM
Status last verified
Apr 2013
First submitted
3 Jun 2013
Last updated
21 Jun 2013
Results posted
No
Data monitoring committee
Yes

Publications

  • Chang FC, Huang JJ, Wallace CG, Hsiao YC, Chen ZC, Liao YF, Chen PK. Comparison of Facial Growth between Two Nasoalveolar Molding Techniques in Patients with Unilateral Complete Cleft Lip. Plast Reconstr Surg. 2023 Nov 1;152(5):1078-1083. doi: 10.1097/PRS.0000000000010448. Epub 2023 Mar 21.

    PubMed 36940137
  • Chang CS, Wallace CG, Pai BC, Chiu YT, Hsieh YJ, Chen IJ, Liao YF, Liou EJ, Chen PK. Comparison of two nasoalveolar molding techniques in unilateral complete cleft lip patients: a randomized, prospective, single-blind trial to compare nasal outcomes. Plast Reconstr Surg. 2014 Aug;134(2):275-282. doi: 10.1097/PRS.0000000000000361.

    PubMed 24732649

Questions about this trial

What is this clinical trial studying?

A study testing Grayson's presurgical nasoalveolar molding and Figueroa's presurgical nasoalveolar molding in people with Unilateral Complete Cleft Lip, run by Chang Gung Memorial Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Jun 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The nasal morphology - Nostril height 1 (time frame: (T1) at initial visit). The study lists 14 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01883726, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jun 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in